- Home
- ETON vs ALTI Comparison
ETON vs ALTI Comparison
Compare ETON & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- ALTI
- Stock Information
- Founded
- ETON 2017
- ALTI 2020
- Country
- ETON United States
- ALTI United States
- Employees
- ETON N/A
- ALTI N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- ALTI Investment Managers
- Sector
- ETON Health Care
- ALTI Finance
- Exchange
- ETON Nasdaq
- ALTI Nasdaq
- Market Cap
- ETON 428.5M
- ALTI 406.5M
- IPO Year
- ETON 2018
- ALTI N/A
- Fundamental
- Price
- ETON $14.45
- ALTI $4.14
- Analyst Decision
- ETON Strong Buy
- ALTI
- Analyst Count
- ETON 3
- ALTI 0
- Target Price
- ETON $29.67
- ALTI N/A
- AVG Volume (30 Days)
- ETON 616.4K
- ALTI 194.1K
- Earning Date
- ETON 08-07-2025
- ALTI 08-08-2025
- Dividend Yield
- ETON N/A
- ALTI N/A
- EPS Growth
- ETON N/A
- ALTI N/A
- EPS
- ETON N/A
- ALTI N/A
- Revenue
- ETON $48,327,000.00
- ALTI $214,086,000.00
- Revenue This Year
- ETON $103.21
- ALTI $24.86
- Revenue Next Year
- ETON $51.34
- ALTI $10.74
- P/E Ratio
- ETON N/A
- ALTI N/A
- Revenue Growth
- ETON 40.88
- ALTI N/A
- 52 Week Low
- ETON $3.22
- ALTI $2.33
- 52 Week High
- ETON $21.48
- ALTI $5.25
- Technical
- Relative Strength Index (RSI)
- ETON 41.91
- ALTI 65.43
- Support Level
- ETON $13.51
- ALTI $3.94
- Resistance Level
- ETON $14.70
- ALTI $4.24
- Average True Range (ATR)
- ETON 0.78
- ALTI 0.24
- MACD
- ETON 0.11
- ALTI -0.01
- Stochastic Oscillator
- ETON 79.53
- ALTI 79.51
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.